MBNL1 and breast carcinoma: The results indicated that expression of MBNL1-AS1 markedly decreased in breast cancer and high-metastatic BC cell lines, which was in line with the studies that revealed that MBNL1-AS1 levels were downregulated in colorectal cancer, NSCLC, retinoblastoma, and bladder cancer.